Spring Bank Pharmaceuticals, Inc. Gains 44.38%
Tue, Jul 28, 2020 at 05:30 PM
Spring Bank Pharmaceuticals, Inc. (SBPH:NASDAQ) rocketted at $2.57, representing a gain of 44.4%. On Mon 27 Jul 20, SBPH:NASDAQ hit a New 2-Week Intraday High of $1.9. From Mon 13 Jul 20, the stock recorded 60.00% Up Days and 63.64% Green Days
About Spring Bank Pharmaceuticals, Inc. (SBPH:NASDAQ)
Spring Bank Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of a novel class of therapeutics using a proprietary small molecule nucleic acid hybrid, or SMNH, chemistry platform.
Top 10 Gainers:
- Eastman Kodak Company (KODK:NYSE), 203.05%
- Sypris Solutions, Inc. (SYPR:NASDAQ), 123.29%
- Golden Bull Limited (DNJR:NASDAQ), 46.63%
- Spring Bank Pharmaceuticals, Inc. (SBPH:NASDAQ), 44.38%
- SPAR Group, Inc. (SGRP:NASDAQ), 40.24%
- Exela Technologies, Inc. (XELA:NASDAQ), 36.48%
- Vocera Communications, Inc. (VCRA:NYSE), 34.02%
- Sequential Brands Group, Inc. (SQBG:NASDAQ), 31.59%
- Francesca's Holdings Corporation (FRAN:NASDAQ), 28.76%
- Trxade Group, Inc. (MEDS:NASDAQ), 24.76%